PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrob...
3 months ago